Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Sysmex ( (JP:6869) ).
Sysmex Corporation reported a decline in its financial performance for the first three months of the fiscal year ending March 31, 2026, with significant decreases in net sales, operating profit, and profit before tax compared to the same period last year. Despite these declines, Sysmex has revised its financial forecast for the full year, projecting an increase in net sales and profits, and announced a commemorative dividend in celebration of its 30th anniversary of listing, indicating a strategic focus on long-term growth and shareholder value.
The most recent analyst rating on (JP:6869) stock is a Buy with a Yen3500.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.
More about Sysmex
Sysmex Corporation operates in the healthcare industry, specializing in the development and manufacturing of diagnostic systems and reagents. The company is focused on providing innovative solutions for clinical laboratory testing, contributing to the improvement of healthcare services globally.
Average Trading Volume: 1,601,053
Technical Sentiment Signal: Sell
Current Market Cap: Yen1546.5B
Learn more about 6869 stock on TipRanks’ Stock Analysis page.